Astria Therapeutics, Inc. (ATXS) CEO Jill Milne on Q3 2021 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts
150.89K Followers

Q3: 2021-11-10 Earnings Summary

10-Q
EPS of -$0.61 misses by $0.11 | Revenue of $0.00 beats by $0.00

Astria Therapeutics, Inc. (NASDAQ:ATXS) Q3 2021 Earnings Conference Call November 10, 2021 8:30 AM ET

Company Participants

Andrea Matthews - Senior Vice President, Corporate Affairs
Jill Milne - Chief Executive Officer
Andy Nichols - Chief Scientific Officer
Andrew Komjathy - Chief Commercial Officer
Noah Clauser - Chief Financial Officer

Conference Call Participants

Hartaj Singh - Oppenheimer
Suji Jeong - Jefferies
Laura Chico - Wedbush Securities
Joe Pantginis - H.C. Wainwright

Operator

Good day and thank you for standing by. Welcome to the Q3 2021 Astria Therapeutics Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]

I would now like to hand the conference over to your speaker today, Andrea Matthews, Senior Vice President, Corporate Affairs. Please go ahead.

Andrea Matthews

Thank you, Elisa. Welcome to today’s Astria Therapeutics conference call, where we will provide a corporate update and review our third quarter 2021 financial results.

With me today are; Jill Milne, Chief Executive Officer; Andy Nichols, Chief Scientific Officer; Andrew Komjathy, Chief Commercial Officer; and Noah Clauser, Chief Financial Officer. We issued a press release this morning, summarizing our corporate update and our Q3 2021 financial results, which we will reference on today’s call, and is available on our website.

We’re also using slides during today’s call that are available within the Events & Presentation section in the Investors’ part of our website. I would like to note that during today’s call, as mentioned on Slide 2, we will make statements related to our business based on current and future expectations that may be considered forward-looking statements under applicable Securities Laws and Regulations.

Actual results may differ materially from those indicated by these statements as a result of a variety of risks and uncertainties, including

Recommended For You

About ATXS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on ATXS